Gene · 5587
Papers3,376
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,376
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Common Core Genes Play Vital Roles in Gastric Cancer With Different Stages. | Front Genet | 2022 | 35938042 | PubTator, text mining | PubMed |
| Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases. | ACS Omega | 2022 | 35936442 | PubTator, text mining | PubMed |
| A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma. | Front Immunol | 2022 | 35935986 | PubTator, text mining | PubMed |
| Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3. | Peptides | 2022 | 35932909 | PubTator, text mining | PubMed |
| Proteome and phosphoproteome signatures of recurrence for HPV+ head and neck squamous cell carcinoma. | Commun Med (Lond) | 2022 | 35919862 | PubTator, text mining | PubMed |
| Nucleosome remodeling and deacetylation complex and MBD3 influence mouse embryonic stem cell naïve pluripotency under inhibition of protein kinase C. | Cell Death Discov | 2022 | 35915078 | PubTator, text mining | PubMed |
| MAPPINGS, a tool for network analysis of large phospho-signalling datasets: application to host erythrocyte response to Plasmodium infection. | Curr Res Microb Sci | 2022 | 35909628 | PubTator, text mining | PubMed |
| Sensitization of cancer cells towards Cisplatin and Carboplatin by protein kinase D inhibitors through modulation of ATP7A/B (copper transport ATPases). | Cancer Treat Res Commun | 2022 | 35908410 | PubTator, text mining | PubMed |
| Crystallographic mining of ASK1 regulators to unravel the intricate PPI interfaces for the discovery of small molecule. | Comput Struct Biotechnol J | 2022 | 35891784 | PubTator, text mining | PubMed |
| Activation and Pharmacological Regulation of Inflammasomes. | Biomolecules | 2022 | 35883561 | PubTator, text mining | PubMed |
| Salivary gland polymorphous adenocarcinoma: Clinicopathological features and gene alterations in 36 Japanese patients. | J Oral Pathol Med | 2022 | 35880805 | PubTator, text mining | PubMed |
| P-Rex1 Signaling Hub in Lower Grade Glioma Patients, Found by In Silico Data Mining, Correlates With Reduced Survival and Augmented Immune Tumor Microenvironment. | Front Oncol | 2022 | 35875157 | PubTator, text mining | PubMed |
| NEAT1/MALAT1/XIST/PKD--Hsa-Mir-101-3p--DLGAP5 Axis as a Novel Diagnostic and Prognostic Biomarker Associated With Immune Cell Infiltration in Bladder Cancer. | Front Genet | 2022 | 35873473 | PubTator, text mining | PubMed |
| Role of extracellular vesicles in lung diseases. | Chin Med J (Engl) | 2022 | 35866573 | PubTator, text mining | PubMed |
| Ferroptosis: A Novel Therapeutic Direction of Spinal Cord Injury. | Comput Math Methods Med | 2022 | 35866036 | PubTator, text mining | PubMed |
| The mitochondrial unfolded protein response (UPRmt): shielding against toxicity to mitochondria in cancer. | J Hematol Oncol | 2022 | 35864539 | PubTator, text mining | PubMed |
| A protein kinase D inhibitor suppresses AKT on T cells and antagonizes cancer immunotherapy by anti-PD-1. | Int Immunol | 2022 | 35849090 | PubTator, text mining | PubMed |
| Respiratory syncytial virus disrupts the airway epithelial barrier by decreasing cortactin and destabilizing F-actin. | J Cell Sci | 2022 | 35848790 | PubTator, text mining | PubMed |
| Protein kinase D: A therapeutic target in experimental alcoholic pancreatitis. | Biochim Biophys Acta Mol Basis Dis | 2022 | 35835415 | PubTator, text mining | PubMed |
| Role of NLRP3 Inflammasome in Rheumatoid Arthritis. | Front Immunol | 2022 | 35833125 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5587/papers?page=24